You Jeng-Fu, Lee Cheng-Chi, Lee Yun-Shien, Chern Yih-Jong, Liao Chun-Kai, Hsu Hung-Chih
Department of Colon and Rectal Surgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
College of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Transl Oncol. 2025 Feb;52:102198. doi: 10.1016/j.tranon.2024.102198. Epub 2024 Dec 9.
INTRODUCTION: Natural killer (NK) cell activity (NKA) is downregulated in patients with colorectal cancer (CRC), and its dysfunction is possibly associated with increased risk of recurrence. However, its role in prognosis of CRC remains unclear. Prior research has shown that surgical stress can suppress NKA. This study explores the relationship between NK cell/NKA and clinicopathological factors during the perioperative period in patients with CRC. METHODS: We prospectively enrolled 45 patients with CRC. Venous blood samples were collected preoperatively and on postoperative day 3 (POD3) and 30 (POD30). NKA was assessed by measuring the plasma levels of NK cell-secreted IFN-γ. RESULTS: NKA was significantly reduced on POD3 compared with baseline levels before surgery but showed significant recovery by POD30. NKA on POD30 was considerably higher in patients with advanced disease stages or one or more high-risk preoperative factors. Additionally, a higher NKA recovery in patients with advanced stage exhibited improved recurrence-free survival (RFS) and progression-free survival (PFS) (hazards ratio (HR): 0.2442). Furthermore, an increased percentage of CD56 NK cells and a higher CD56/CD56 NK cell ratio postoperatively on POD30 were associated with better RFS/PFS (HR: 0.2732, P = 0.0433 and HR: 0.2193, P = 0.024, respectively). CONCLUSIONS: Our findings indicate that a notable postoperative increase in CD56 NK cells on POD30, both in percentage and ratio, correlates with a more favorable prognosis in CRC patients. Additionally, higher recovery rates of NKA in patients with advanced stages may offer potential applications in risk stratification and the development of treatment strategies for CRC.
引言:自然杀伤(NK)细胞活性(NKA)在结直肠癌(CRC)患者中下调,其功能障碍可能与复发风险增加有关。然而,其在CRC预后中的作用仍不清楚。先前的研究表明,手术应激可抑制NKA。本研究探讨CRC患者围手术期NK细胞/NKA与临床病理因素之间的关系。 方法:我们前瞻性纳入了45例CRC患者。在术前、术后第3天(POD3)和第30天(POD30)采集静脉血样本。通过测量NK细胞分泌的干扰素-γ的血浆水平来评估NKA。 结果:与手术前的基线水平相比,POD3时NKA显著降低,但到POD30时显著恢复。疾病分期较晚或有一个或多个术前高危因素的患者在POD30时的NKA明显更高。此外,晚期患者中较高的NKA恢复率表现出无复发生存期(RFS)和无进展生存期(PFS)改善(风险比(HR):0.2442)。此外,术后POD30时CD56 NK细胞百分比增加和CD56/CD56 NK细胞比率升高与更好的RFS/PFS相关(HR分别为:0.2732,P = 0.0433和HR:0.2193,P = 0.024)。 结论:我们的研究结果表明,术后第30天CD56 NK细胞在百分比和比率上的显著增加与CRC患者更有利的预后相关。此外,晚期患者中较高的NKA恢复率可能在CRC的风险分层和治疗策略制定中具有潜在应用价值。
Ann Surg Oncol. 2018-9-5
Cancer Immunol Immunother. 2019-5-3
Cancer Immunol Immunother. 2025-3-8
Support Care Cancer. 2023-10-11
Cancer Immunol Immunother. 2023-6
Front Oncol. 2023-1-4
Expert Opin Drug Metab Toxicol. 2021-12